3-19-19 – Yulin, Shaanxi Province, China
Reporters in China were informed that international trade negotiations about the magnesium trade, with the U.S. Asia-Pacific Group, have resulted in formation of a joint venture agreement to establish the Xinghe Trade and Technology Company. The company is focused on cooperation in the international magnesium industry trade.I haven't dug very deep into this yet, but this looks like something more substantial than it appeared on the surface. Will be watching for follow through. I am still holding my position.
The horizontal on the chart is at $1, that's the ceiling for the stock going back to its IPO. There was a brief spike on a fake takeover report several years ago. Although that also gave the stock a black eye in the eyes of investors, I view that as a "sneak peek" at this company's underlying value. For a brief moment the market believed that offer was real.
The smiley is when I posted on the stock and took my position. This stock still has 10X+ potential in an inflationary growth environment. I am holding off on adding here because of my general bearishness. I prefer accumulating gold and silver miners right now.
As for Pfizer, every morning I wake up and hope today is the day I read the government has ordered a halt to mass mRna shot campaigns over heart attack risk. It's a turkey trade in the sense of "the turkey problem." The trick is managing the position to maximize time in the trade, while minimizing losses, waiting for Pfizer's turkey day.